CAS 463930-25-8

Bay 55-9837

CAS: 463930-25-8

Selective VPAC2 agonist; EC50: 0.4 nM (VPAC2), 100 nM (VPAC1), >1000 nM (PAC1). Enhances insulin secretion, reduces HIV-1 replication.

Fórmula: C₁₆₇H₂₇₀N₅₂O₄₆

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 3742.29

Ref: TM-TP2071

Bay 55-9837

CAS: 463930-25-8

Bay 55-9837 is a selective GABA-B receptor agonist that has been shown to lower high blood pressure and improve insulin sensitivity in rats. Bay 55-9837 binds to the GABA-B receptors in the brain and has been shown to inhibit the production of vasoactive intestinal peptide, which is a hormone that causes contraction of blood vessels. Studies have also shown that Bay 55-9837 has a growth factor activity, which may be due to its ability to increase epidermal growth factor levels. Bay 55-9837 has demonstrated safety and efficacy in animal studies and is currently in Phase II clinical trials for diabetes mellitus type 2.

Fórmula: C₁₆₇H₂₇₀N₅₂O₄₆

Pureza: Min. 95%

Peso molecular: 3,742.3 g/mol

Ref: 3D-NTA93025